Top compounds associated with response to CAPZB


Feature Type Standardized
Nominal ANOVA
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.014 0.7
mRNA ATRA FIMM pan-cancer AAC 0.063 0.7
mRNA Sorafenib FIMM pan-cancer AAC 0.071 0.7
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.015 0.7
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA Bax channel blocker CTRPv2 pan-cancer AAC -0.015 0.7
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.014 0.7
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
Download CSV